←Back to structures
pre3_saliva_scaffold_7_prodigal-single.1__X__X__00303
Bact-Virpre3_saliva_scaffold_7_prodigal-single.1__X__X__00303
Identity
- Kingdom:
- phage
Quality
52.4
mean pLDDT
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 165-309
Domain cluster:
representative
CATH (28)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 5tgnA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 46.0 | 5.17e-01 | 89.7% | 94.5% |
| 1of5B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 52.0 | 5.51e-01 | 91.7% | 93.8% |
| 1ar0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 49.0 | 5.20e-01 | 92.4% | 89.6% |
| 2g30A02 | 3.30.310.10 | Alpha Beta › 2-Layer Sandwich › TATA-Binding Protein › TATA-Binding Protein | 0.65 | 30.0 | 3.29e-01 | 90.3% | 51.7% |
| 2oojA00 | 2.40.350.10 | Mainly Beta › Beta Barrel › AOC barrel-like › SO1590-like | 0.64 | 32.0 | 3.40e-01 | 81.4% | 51.9% |
| 2q03A00 | 2.40.350.10 | Mainly Beta › Beta Barrel › AOC barrel-like › SO1590-like | 0.64 | 34.0 | 3.62e-01 | 82.8% | 56.4% |
| 3n8bA00 | 3.10.450.700 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 29.0 | 3.97e-01 | 89.7% | 82.7% |
| 3ecfA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 45.0 | 4.79e-01 | 92.4% | 83.6% |
| 2imjD01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 48.0 | 4.93e-01 | 100.0% | 83.1% |
| 6p3lA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 44.0 | 4.90e-01 | 91.0% | 93.0% |
| 3q90B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 46.0 | 4.83e-01 | 91.7% | 87.7% |
| 3nv0B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 46.0 | 4.72e-01 | 89.7% | 84.6% |
| 4kz1A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.60 | 50.0 | 5.15e-01 | 89.0% | 94.1% |
| 3b8lA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 48.0 | 4.89e-01 | 91.7% | 87.9% |
| 2qiyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 48.0 | 5.03e-01 | 91.7% | 93.3% |
| 3cnxA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 48.0 | 4.94e-01 | 89.0% | 91.3% |
| 3er7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 46.0 | 4.91e-01 | 92.4% | 96.7% |
| 1jkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 47.0 | 4.78e-01 | 91.7% | 87.1% |
| 5aigA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 43.0 | 4.64e-01 | 89.7% | 90.3% |
| 2gexA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 46.0 | 4.67e-01 | 92.4% | 83.6% |
| 3f14A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 41.0 | 4.56e-01 | 88.3% | 92.9% |
| 3lydA01 | 3.40.1000.10 | Alpha Beta › 3-Layer(aba) Sandwich › Protein Transport Mog1p; Chain A › Mog1/PsbP, alpha/beta/alpha sandwich | 0.57 | 32.0 | 3.28e-01 | 93.8% | 54.2% |
| 3ebtA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 44.0 | 4.57e-01 | 89.7% | 90.1% |
| 2cc3A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.56 | 46.0 | 4.71e-01 | 92.4% | 91.0% |
| 2h36X00 | 3.30.160.300 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.54 | 35.0 | 4.04e-01 | 79.3% | 88.0% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.54 | 45.0 | 4.23e-01 | 89.0% | 83.1% |
| 4pj2A00 | 2.40.128.460 | Mainly Beta › Beta Barrel › Lipocalin › Periplasmic lysozyme inhibitor of I-type lysozyme | 0.54 | 39.0 | 4.25e-01 | 95.2% | 90.9% |
| 4puxA00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.51 | 38.0 | 3.69e-01 | 90.3% | 71.3% |
ECOD (59)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 5031081 | 243.3.1.59 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › GvpO | 0.76 | 40.0 | 5.23e-01 | 93.1% | 92.5% |
| 3678591 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.73 | 41.0 | 5.10e-01 | 91.0% | 88.9% |
| 4586147 | 243.3.1.5 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › FTP | 0.73 | 38.0 | 4.66e-01 | 91.7% | 77.9% |
| 3666026 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.72 | 40.0 | 5.01e-01 | 89.7% | 87.8% |
| 3978258 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.70 | 43.0 | 5.26e-01 | 91.0% | 95.7% |
| 3466699 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.69 | 41.0 | 4.96e-01 | 91.0% | 88.8% |
| 2648443 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.68 | 40.0 | 4.93e-01 | 95.2% | 90.3% |
| 3277868 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 56.0 | 5.82e-01 | 87.6% | 94.0% |
| 3247589 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.67 | 51.0 | 5.32e-01 | 91.0% | 87.2% |
| 4606362 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.67 | 36.0 | 4.57e-01 | 92.4% | 89.4% |
| 3889571 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.66 | 49.0 | 5.28e-01 | 91.7% | 90.2% |
| 3248518 | 243.1.1.12 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TIM21 | 0.66 | 42.0 | 4.49e-01 | 91.7% | 74.0% |
| 3330850 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.66 | 40.0 | 4.74e-01 | 93.1% | 88.0% |
| 3798282 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.66 | 51.0 | 5.41e-01 | 91.7% | 93.6% |
| 4318516 | 243.1.1.92 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26366 | 0.66 | 51.0 | 5.11e-01 | 91.0% | 80.7% |
| 3830041 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.64 | 48.0 | 5.09e-01 | 89.7% | 86.9% |
| 875 | 9.13.1.3 ↗ | beta barrels › Lipocalins/Streptavidin › AOC barrel-like › AOC barrel-like › DUF3224 | 0.64 | 34.0 | 3.62e-01 | 82.8% | 56.4% |
| 3732542 | 331.9.1.4 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › Coatomer_g_Cpla | 0.64 | 30.0 | 3.36e-01 | 89.7% | 54.2% |
| 5038381 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.63 | 49.0 | 5.24e-01 | 97.2% | 94.4% |
| 3710606 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.63 | 50.0 | 5.14e-01 | 92.4% | 88.9% |
| 3431175 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.63 | 39.0 | 4.49e-01 | 94.5% | 88.0% |
| 3254046 | 243.1.1.9 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF1348 | 0.62 | 49.0 | 4.79e-01 | 100.0% | 77.9% |
| 4926981 | 9.13.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › AOC barrel-like › AOC barrel-like | 0.62 | 35.0 | 3.80e-01 | 90.3% | 64.0% |
| 3948878 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.61 | 48.0 | 5.12e-01 | 89.7% | 95.2% |
| 3600301 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.61 | 46.0 | 4.97e-01 | 89.0% | 92.0% |
| 3283292 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.61 | 46.0 | 4.87e-01 | 91.0% | 89.2% |
| 5040084 | 283.2.1.0 ↗ | a+b duplicates or obligate multimers › Creatinase/aminopeptidase-like › gpW/gp25-like › gpW/gp25-like | 0.61 | 36.0 | 3.95e-01 | 92.4% | 70.0% |
| 3217155 | 243.1.1.97 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382_N | 0.61 | 48.0 | 4.81e-01 | 89.7% | 80.7% |
| 3741071 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.61 | 47.0 | 4.80e-01 | 92.4% | 84.3% |
| 3225768 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.61 | 38.0 | 3.63e-01 | 89.7% | 53.5% |
| 3213524 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.60 | 52.0 | 5.09e-01 | 91.7% | 90.3% |
| 3818565 | 881.1.1.1 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › PsbP | 0.60 | 36.0 | 3.52e-01 | 94.5% | 52.9% |
| 4011330 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.60 | 47.0 | 4.84e-01 | 92.4% | 87.4% |
| 4014757 | 9.13.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › AOC barrel-like › AOC barrel-like › DUF3237 | 0.59 | 37.0 | 3.89e-01 | 90.3% | 68.1% |
| 5072383 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.59 | 46.0 | 4.69e-01 | 90.3% | 83.4% |
| 3285746 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.59 | 46.0 | 4.55e-01 | 91.0% | 77.4% |
| 3960172 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.58 | 43.0 | 4.71e-01 | 86.9% | 94.9% |
| 4928158 | 9.13.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › AOC barrel-like › AOC barrel-like | 0.58 | 37.0 | 3.85e-01 | 91.0% | 68.4% |
| 5069097 | 331.9.1.0 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain | 0.58 | 30.0 | 3.23e-01 | 89.7% | 55.8% |
| 4870077 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.58 | 46.0 | 4.77e-01 | 91.7% | 89.8% |
| 3242736 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.58 | 45.0 | 4.62e-01 | 91.7% | 85.7% |
| 3608096 | 331.9.1.4 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › Coatomer_g_Cpla | 0.57 | 28.0 | 3.08e-01 | 90.3% | 55.9% |
| 3726301 | 243.1.1.78 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26534 | 0.57 | 45.0 | 4.65e-01 | 91.0% | 87.9% |
| 3829053 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.56 | 43.0 | 4.36e-01 | 90.3% | 81.4% |
| 3785652 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.56 | 48.0 | 4.71e-01 | 92.4% | 90.0% |
| 3228525 | 241.15.1.0 ↗ | a+b two layers › Type III secretory system chaperone-like › FP (Fbxo7/PI31) dimerization domain › FP (Fbxo7/PI31) dimerization domain | 0.56 | 32.0 | 3.58e-01 | 93.1% | 71.8% |
| 3217509 | 243.1.1.46 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382 | 0.55 | 45.0 | 4.54e-01 | 89.7% | 86.0% |
| 3282693 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.55 | 42.0 | 4.12e-01 | 90.3% | 73.1% |
| 4017051 | 9.13.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › AOC barrel-like › AOC barrel-like › DUF3237 | 0.55 | 35.0 | 3.65e-01 | 89.7% | 66.4% |
| 3418771 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.54 | 42.0 | 4.47e-01 | 91.7% | 91.5% |
| 3203571 | 9.13.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › AOC barrel-like › AOC barrel-like › DUF3237 | 0.54 | 36.0 | 3.67e-01 | 90.3% | 68.6% |
| 3600667 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.54 | 49.0 | 3.62e-01 | 100.0% | 63.9% |
| 3681671 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.54 | 46.0 | 4.57e-01 | 91.7% | 91.3% |
| 3268067 | 708.1.1.0 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain | 0.54 | 36.0 | 3.79e-01 | 84.8% | 73.3% |
| 3700544 | 331.9.1.3 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › Coatomer_b_Cpla | 0.54 | 30.0 | 3.17e-01 | 89.7% | 60.0% |
| 3217156 | 243.1.1.46 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382 | 0.54 | 45.0 | 4.57e-01 | 91.0% | 93.6% |
| 3635091 | 9.13.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › AOC barrel-like › AOC barrel-like › DUF3237 | 0.53 | 41.0 | 3.92e-01 | 90.3% | 69.8% |
| 4552582 | 243.3.1.52 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › UPF0182 | 0.52 | 33.0 | 3.59e-01 | 91.7% | 77.4% |
| 3783000 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.52 | 33.0 | 3.86e-01 | 83.4% | 94.7% |